Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. The lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen...
9th May 2019
Watrium supports the listing of DF Capital on AIM as cornerstone investor.
17th April 2019
Watrium partners with HitecVision by acquiring the interests of the Gjedebo family in HitecVision AS.
28th February 2019
Watrium’s portfolio company Flexiteek International, the global leader in synthetic teak decking and the 2G technology, has reached an agreement to acquire Wilks, manufacturer, and supplier of Dek-King synthetic teak...
17th October 2018
Watrium strengthens its investment team with two highly experienced investment professionals.
22nd June 2018
The combined entity of American Traffic Solutions, Highway Toll Administration and Watrium-owned Euro Parking Collection has rebranded to Verra Mobility and announced that the company will perform a reverse listing...
6th June 2018
Watrium has participated in the Series B financing of CMR Surgical, a private company developing a next-generation surgical robot for universal minimal access surgery.
10th April 2018
Watrium has merged Euro Parking Collection Plc (EPC) into American Traffic Solutions (ATS) in a deal that will facilitate further growth and global expansion.
15th January 2018
Watrium has contracted 4Service’s subsidiary De 3 Stuer to operate the staff restaurant at Oslo Atrium in Bjørvika, Oslo, Norway.
23rd October 2017
Watrium has doubled its shareholding in Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer, through a private placement. For more information, see the press release from Ultimovacs (Norwegian only)....
